"Timing, Prevalence, and Impact of Early Recurrence of Atrial Tachyarrh" by Lucas V. Boersma, Andrea Natale et al.
 

Timing, Prevalence, and Impact of Early Recurrence of Atrial Tachyarrhythmias After Pulsed Field Ablation: Secondary Analysis of PULSED AF

Document Type

Conference Proceeding

Publication Date

5-2024

Publication Title

Heart Rhythm

Abstract

Background: Early recurrence of atrial tachyarrhythmias (ERATs) within three months following radiofrequency or cryoballoon catheter ablation for atrial fibrillation (AF) is common (w50% in trials with weekly monitoring of arrhythmias during the blanking period) and often considered transient. ERAT has been linked with early pro-arrhythmogenic processes after thermal ablation. However, pulsed field ablation (PFA) is a non-thermal energy source in which ERAT is not well described. Objective: To analyze ERAT in AF patients undergoing ablation using PFA in the PULSED AF trial. Methods: A total of 186 paroxysmal and 174 persistent AF patients were monitored immediately post ablation by weekly and symptomatic trans-telephonic monitoring (TTM) through 12 months, and 12-lead ECGs at 3, 6, and 12 months. This analysis was limited to 294 patients (154 paroxysmal, 140 persistent AF) that had ≥10 rhythm assessments during the 90-day blanking period. ERAT was defined as any instance of ≥30s of atrial fibrillation, atrial flutter, or atrial tachycardia on TTM or ≥10s on ECG, both within the blanking period. Late recurrence of atrial tachyarrhythmias (LRATs) was defined as observed atrial tachyarrhythmias between 90 days and 12 months. Results: Overall prevalence of ERAT was 27.1% in paroxysmal and 31.6% in persistent AF patients. Median time to first documented ERAT (i.e., ERAT onset) was 19 [5-56] days in paroxysmal and 7.5 [4-14] days in persistent AF patients. In patients with ERAT, 71% had ERAT onset within the first month post-procedure vs. 12% within the second and 17% in the third month. Presence of ERAT was associated with LRAT in paroxysmal (HR 6.4 (95%c.i. 3.6-11.3)) and persistent (HR 3.8 (95%c.i. 2.2-6.6)) AF patients. Yet, in 29.4% of paroxysmal and 34.3% of persistent AF patients with ERAT, LRAT was not observed. Conclusion: The prevalence of ERAT post AF ablation with PFA is lower compared to historic rates of thermal energies. However, the concept of a blanking period post PFA is still valid as 1/3rd of patients with ERAT do not develop LRAT during follow-up and may not need re-ablation.

Volume

21

Issue

5S

First Page

S114

Comments

Heart Rhythm Society Annual Meeting, May 16-19, 2024, Boston, MA

Last Page

S115

DOI

10.1016/j.hrthm.2024.03.1804

Share

COinS